|
000
| 01873cam 2200289za 4500 |
|---|
| 001 | 9.819702 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107143029 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 160721s2016 onc ob f000 0 eng d |
|---|
| 020 | |a978-0-660-05699-9 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-195/1-2016E-PDF |
|---|
| 245 | 00|aGood label and package practices guide for prescription drugs |h[electronic resource]. |
|---|
| 260 | |aOttawa : |bHealth Canada, |c2016. |
|---|
| 300 | |aiii, 71 p. |
|---|
| 500 | |aIssued also in French under title: Guide des bonnes pratiques d’étiquetage et d’emballage pour les médicaments sur ordonnance. |
|---|
| 500 | |a"June 30, 2016." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |aThe objective of the Good Label and Package Practices Guide for Prescription Drugs is to provide direction to sponsors, manufacturers and license holders (to be referred to as ‘sponsors’ within this guide) in designing safe and clear labels and packages. It is essential that all labelling and packaging regulatory requirements be met. The recommendations provided in this guide will aid sponsors in the organization of (a) information required by the regulations, and (b) other complementary information important to the proper identification, selection, and use of the product. The information is presented to support the design and development of labels and packages that are clear, effective, and minimize the risk of errors causing harm. |
|---|
| 692 | 07|2gccst|aPrescription drugs |
|---|
| 692 | 07|2gccst|aDrug labelling |
|---|
| 692 | 07|2gccst|aPackaging |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tGuide des bonnes pratiques d'étiquetage et d'emballage pour les médicaments sur ordonnance |w(CaOODSP)9.819703 |
|---|
| 856 | 40|qPDF|s930 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H164-195-1-2016-eng.pdf |
|---|